
Asta Bio
Our technology combines 211-Astatine, the most druggable alpha-emitting radioisotope, with our proprietary Radiobody™ targeting molecules.
About Asta Bio
This innovative approach ensures precise radiation delivery, destroying tumor cells by breaking their DNA strands without harming surrounding healthy cells.
Recent Funding lists Asta Bio under Health and bio (also Logistics and mobility). It went through IndieBio (IndieBio NY 09). It was founded by Ahmad-Reza Saadat and Rebekah O'Donnell.
Funding rounds
- Website created
- IndieBio NY 09
IIndieBio · batchSource: indiebio.co
Founders and team
AS
Ahmad-Reza Saadat Chief Executive Officer, Co-Foundersource: astabiotx.com- RORebekah O'Donnell Chief Scientific Officer, Co-Foundersource: astabiotx.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Asta Bio: questions and answers
- Who invested in Asta Bio?
- Investors on record for Asta Bio: IndieBio.
- Who founded Asta Bio?
- Asta Bio was founded by Ahmad-Reza Saadat (Chief Executive Officer, Co-Founder) and Rebekah O'Donnell (Chief Scientific Officer, Co-Founder).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/asta-bio (get a free API key).